Cover Image

Evaluation of Surrogate Endpoints Based on Meta-Analysis with Surrogate Indices

Fuente: arXiv

Saved in:

Bibliographic Details
Main Authors:	Stijven, Florian, Gilbert, Peter B.
Format:	Preprint
Published:	2025
Subjects:	Methodology Applications
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A Reflection on the Impact of Misspecifying Unidentifiable Causal Inference Models in Surrogate Endpoint Evaluation
by: Deliorman, Gokce, et al.
Published: (2024)

Bias in Meta-Analytic Modeling of Surrogate Endpoints in Cancer Screening Trials
by: Long, James P., et al.
Published: (2025)

Tutorial for Surrogate Endpoint Validation Using Joint modeling and Mediation Analysis
by: Coent, Quentin Le, et al.
Published: (2025)

On the Role of Surrogates in Conformal Inference of Individual Causal Effects
by: Gao, Chenyin, et al.
Published: (2024)

Correcting for Missing Data When Evaluating Surrogate Markers in a Clinical Trial
by: Lotspeich, Sarah C., et al.
Published: (2026)

Surrogate modeling with functional nonlinear autoregressive models (F-NARX)
by: Schär, Styfen, et al.
Published: (2024)

Causal Judge Evaluation: Calibrated Surrogate Metrics for LLM Systems
by: Landesberg, Eddie, et al.
Published: (2025)

Evaluating the Surrogate Index as a Decision-Making Tool Using 200 A/B Tests at Netflix
by: Zhang, Vickie, et al.
Published: (2023)

RISE: Two-Stage Rank-Based Identification of High-Dimensional Surrogate Markers Applied to Vaccinology
by: Hughes, Arthur, et al.
Published: (2025)

Dynamic Classification of Latent Disease Progression with Auxiliary Surrogate Labels
by: Cai, Zexi, et al.
Published: (2024)

A Surrogate Endpoint Based Provisional Approval Causal Roadmap
by: Gilbert, Peter B., et al.
Published: (2024)

Assumption-Lean Post-Integrated Inference with Surrogate Control Outcomes
by: Du, Jin-Hong, et al.
Published: (2024)

Multi-Dimensional Composite Endpoint Analysis via the Choquet Integral: Block Recurrent Encoding and Comparative Advantage Mapping
by: Tanboga, Ibrahim Halil
Published: (2026)

Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials
by: Maity, Arnab Kumar, et al.
Published: (2024)

Bayesian Optimization Sequential Surrogate (BOSS) Algorithm: Fast Bayesian Inference for a Broad Class of Bayesian Hierarchical Models
by: Li, Dayi, et al.
Published: (2024)

Generative Bayesian Computation as a Scalable Alternative to Gaussian Process Surrogates
by: Polson, Nick, et al.
Published: (2026)

Proximal Causal Inference for Modified Treatment Policies
by: Olivas-Martinez, Antonio, et al.
Published: (2025)

Optimal Sampling for Generalized Linear Model under Measurement Constraint with Surrogate Variables
by: Shen, Yixin, et al.
Published: (2025)

Salvaging Forbidden Treasure in Medical Data: Utilizing Surrogate Outcomes and Single Records for Rare Event Modeling
by: Yin, Xiaohui, et al.
Published: (2025)

Efficient estimation of cumulative incidence curves via data fusion with surrogates: application to integrated analysis of vaccine trial and immunobridging data
by: Zhao, Pan, et al.
Published: (2026)

Vaccine sieve analysis on deep sequencing data using competing risks Cox regression with failure type subject to misclassification
by: Peng, James, et al.
Published: (2025)

Assessing variable importance in survival analysis using machine learning
by: Wolock, Charles J., et al.
Published: (2023)

Study Duration Prediction for Clinical Trials with Time-to-Event Endpoints Using Mixture Distributions Accounting for Heterogeneous Population
by: Zhang, Hong, et al.
Published: (2023)

Power and Sample Size Calculations for Bayes Factors in two-arm clinical Phase II Trials with binary Endpoints
by: Kelter, Riko
Published: (2026)

Network Meta Analysis of Mean Survival
by: Apsemidis, Anastasios, et al.
Published: (2025)

Optimal sequential two-stage Bayes Factor Design for two-arm clinical Phase II Trials with binary Endpoints
by: Kelter, Riko
Published: (2026)

A Utility Score Framework for Dose Optimization Studies with Binary Efficacy-Safety Endpoints: Sample Size Determination and Bias Characterization
by: Gu, Xuemin, et al.
Published: (2026)

Toward Valid Generative Clinical Trial Data with Survival Endpoints
by: Chassat, Perrine, et al.
Published: (2025)

Personalized Treatment Hierarchies in Bayesian Network Meta-Analysis
by: Wigle, Augustine, et al.
Published: (2026)

Estimation and Inference for Win Measures with Multiple Ordinal Endpoints Subject to Missingness
by: Liu, Yi, et al.
Published: (2026)

Practical Process Capability Indices Workflows
by: Jiang, Fei, et al.
Published: (2026)

Macroscopic Activity-Based Modeling of Urban Active Mobility
by: Azaïs, Romain, et al.
Published: (2026)

Evaluation of Individual and Trial Level Association Metrics in the Validation of a Binary Surrogate Endpoint for a True Time-to-Event Endpoint
by: Ge, Renee Y., et al.
Published: (2026)

A Direct Variance Estimation (DiVE) for Meta-Analysis of Median Differences
by: Okuda, Tadahisa, et al.
Published: (2026)

Meta-analysis of Censored Adverse Events
by: Qi, Xinyue, et al.
Published: (2021)

Estimation and Inference of the Win Ratio for Two Hierarchical Endpoints Subject to Censoring and Missing Data
by: Liu, Yi, et al.
Published: (2026)

Doubly-Robust Bayesian Estimation of Optimal Individualized Treatment Rules using Network Meta-Analysis
by: Wigle, Augustine, et al.
Published: (2026)

Robust multiple method comparison and transformation
by: Dufey, Florian
Published: (2022)

Debiasing hazard-based, time-varying vaccine effects using vaccine-irrelevant infections: An observational extension of a pivotal Phase 3 COVID-19 vaccine efficacy trial
by: Ashby, Ethan, et al.
Published: (2025)

Refactor Analysis: Predictive Evaluations of Factor Models and Dimensionality
by: Hardy, Michael
Published: (2026)